Apollo Endosurgery revenue was $42.05 m in FY, 2020
Apollo Endosurgery revenue breakdown by business segment: 55.8% from Endoscopic Suturing System, 33.2% from Intragastric Balloon, 7.3% from Surgical and 3.7% from Other
Apollo Endosurgery revenue breakdown by geographic segment: 43.2% from US and 56.8% from Non US
FY, 2019 | FY, 2018 | FY, 2017 | |
---|---|---|---|
Surgical | $3.71 m | $18.71 m | $27.59 m |
US Orbera Starter Kit Sales | $862 k | ||
Endo-bariatric, excluding US Orbera Starter Kit Sales | $35.06 m | ||
Other | $1.85 m | $1.03 m | $794 k |
Endoscopic Suturing System | $28.31 m | $23.38 m | |
Intragastric Balloon | $16.84 m | $17.74 m |
FY, 2019 | FY, 2018 | FY, 2017 | |
---|---|---|---|
US | $21.92 m | $28.21 m | $32.45 m |
Non US | $28.79 m | $32.65 m | $31.86 m |
Craft can deliver 250+ data points of financial, operating, and human capital indicators on companies via API.